

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 7.16890391 |
| 2 | nuclear pore organization (GO:0006999) | 6.17408110 |
| 3 | regulation of NFAT protein import into nucleus (GO:0051532) | 5.46529356 |
| 4 | drug transmembrane transport (GO:0006855) | 5.07151340 |
| 5 | urate metabolic process (GO:0046415) | 5.04552353 |
| 6 | cellular response to nerve growth factor stimulus (GO:1990090) | 5.02351660 |
| 7 | response to nerve growth factor (GO:1990089) | 5.02351660 |
| 8 | pore complex assembly (GO:0046931) | 5.02293881 |
| 9 | regulation of RNA export from nucleus (GO:0046831) | 4.91502566 |
| 10 | lysine metabolic process (GO:0006553) | 4.77017883 |
| 11 | lysine catabolic process (GO:0006554) | 4.77017883 |
| 12 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 4.58570402 |
| 13 | mitotic chromosome condensation (GO:0007076) | 4.56569018 |
| 14 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 4.50709766 |
| 15 | regulation of mitotic spindle organization (GO:0060236) | 4.44201520 |
| 16 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.36678272 |
| 17 | regulation of nucleobase-containing compound transport (GO:0032239) | 4.32704793 |
| 18 | DNA unwinding involved in DNA replication (GO:0006268) | 4.32086605 |
| 19 | ribosome assembly (GO:0042255) | 4.10471913 |
| 20 | phosphate ion transport (GO:0006817) | 4.07365148 |
| 21 | drug catabolic process (GO:0042737) | 4.05310723 |
| 22 | drug transport (GO:0015893) | 4.03850890 |
| 23 | histone H3-K36 demethylation (GO:0070544) | 3.85844227 |
| 24 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.81649783 |
| 25 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 3.78199479 |
| 26 | protein complex localization (GO:0031503) | 3.72718522 |
| 27 | cellular protein complex localization (GO:0034629) | 3.67835863 |
| 28 | exogenous drug catabolic process (GO:0042738) | 3.67524888 |
| 29 | protein localization to endosome (GO:0036010) | 3.66713472 |
| 30 | phosphate ion transmembrane transport (GO:0035435) | 3.63142609 |
| 31 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.60518927 |
| 32 | mitotic sister chromatid cohesion (GO:0007064) | 3.58579285 |
| 33 | formation of translation preinitiation complex (GO:0001731) | 3.57681545 |
| 34 | cysteine metabolic process (GO:0006534) | 3.57111273 |
| 35 | heterochromatin organization (GO:0070828) | 3.52360588 |
| 36 | mitotic metaphase plate congression (GO:0007080) | 3.50919343 |
| 37 | sister chromatid cohesion (GO:0007062) | 3.50431252 |
| 38 | protein export from nucleus (GO:0006611) | 3.47307004 |
| 39 | regulation of spindle organization (GO:0090224) | 3.42980382 |
| 40 | Golgi transport vesicle coating (GO:0048200) | 3.40330659 |
| 41 | COPI coating of Golgi vesicle (GO:0048205) | 3.40330659 |
| 42 | proline biosynthetic process (GO:0006561) | 3.38812082 |
| 43 | protein localization to chromosome, centromeric region (GO:0071459) | 3.38793605 |
| 44 | sister chromatid segregation (GO:0000819) | 3.36515299 |
| 45 | cell adhesion mediated by integrin (GO:0033627) | 3.36416780 |
| 46 | nuclear envelope disassembly (GO:0051081) | 3.30815121 |
| 47 | membrane disassembly (GO:0030397) | 3.30815121 |
| 48 | mitotic nuclear envelope disassembly (GO:0007077) | 3.23304255 |
| 49 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.21628305 |
| 50 | nucleoside diphosphate catabolic process (GO:0009134) | 3.19938828 |
| 51 | mitotic sister chromatid segregation (GO:0000070) | 3.14437450 |
| 52 | regulation of heat generation (GO:0031650) | 3.09877809 |
| 53 | establishment of nucleus localization (GO:0040023) | 3.08587000 |
| 54 | mRNA stabilization (GO:0048255) | 3.07880991 |
| 55 | RNA stabilization (GO:0043489) | 3.07880991 |
| 56 | organic cation transport (GO:0015695) | 3.06774326 |
| 57 | protein localization to kinetochore (GO:0034501) | 3.01081662 |
| 58 | oxidative phosphorylation (GO:0006119) | 3.00955860 |
| 59 | IMP biosynthetic process (GO:0006188) | 2.97052385 |
| 60 | IMP metabolic process (GO:0046040) | 2.96695028 |
| 61 | positive regulation of chromosome segregation (GO:0051984) | 2.96624324 |
| 62 | regulation of transcription from RNA polymerase III promoter (GO:0006359) | 2.95655425 |
| 63 | regulation of translational fidelity (GO:0006450) | 2.93521364 |
| 64 | glutamate metabolic process (GO:0006536) | 2.92900819 |
| 65 | regulation of actin nucleation (GO:0051125) | 2.92655511 |
| 66 | peripheral nervous system axon ensheathment (GO:0032292) | 2.92411435 |
| 67 | myelination in peripheral nervous system (GO:0022011) | 2.92411435 |
| 68 | COPII vesicle coating (GO:0048208) | 2.90892999 |
| 69 | glutamine metabolic process (GO:0006541) | 2.90157050 |
| 70 | quaternary ammonium group transport (GO:0015697) | 2.87128117 |
| 71 | regulation of sister chromatid cohesion (GO:0007063) | 2.86036437 |
| 72 | negative regulation of DNA repair (GO:0045738) | 2.84242010 |
| 73 | DNA replication initiation (GO:0006270) | 2.83551519 |
| 74 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.83339971 |
| 75 | response to mercury ion (GO:0046689) | 2.82653608 |
| 76 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.81888482 |
| 77 | excretion (GO:0007588) | 2.80777219 |
| 78 | glyoxylate metabolic process (GO:0046487) | 2.80604434 |
| 79 | metaphase plate congression (GO:0051310) | 2.80213370 |
| 80 | aspartate family amino acid catabolic process (GO:0009068) | 2.80075584 |
| 81 | establishment of chromosome localization (GO:0051303) | 2.77324195 |
| 82 | apoptotic cell clearance (GO:0043277) | 2.76652594 |
| 83 | short-chain fatty acid metabolic process (GO:0046459) | 2.75499463 |
| 84 | establishment of integrated proviral latency (GO:0075713) | 2.75142194 |
| 85 | homocysteine metabolic process (GO:0050667) | 2.70356445 |
| 86 | tricarboxylic acid metabolic process (GO:0072350) | 2.70331946 |
| 87 | response to growth hormone (GO:0060416) | 2.68419803 |
| 88 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.68153715 |
| 89 | nuclear envelope organization (GO:0006998) | 2.66278355 |
| 90 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.66192220 |
| 91 | paraxial mesoderm development (GO:0048339) | 2.65192538 |
| 92 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.63875850 |
| 93 | renal absorption (GO:0070293) | 2.63284725 |
| 94 | chromosome condensation (GO:0030261) | 2.62281224 |
| 95 | pre-miRNA processing (GO:0031054) | 2.61373878 |
| 96 | positive regulation of cell cycle G2/M phase transition (GO:1902751) | 2.61254141 |
| 97 | positive regulation of G2/M transition of mitotic cell cycle (GO:0010971) | 2.61254141 |
| 98 | regulation of translational termination (GO:0006449) | 2.59218002 |
| 99 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.57514807 |
| 100 | regulation of response to osmotic stress (GO:0047484) | 2.55622261 |
| 101 | aromatic amino acid family catabolic process (GO:0009074) | 2.54726832 |
| 102 | negative regulation of receptor activity (GO:2000272) | 2.53951060 |
| 103 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.53875319 |
| 104 | cellular ketone body metabolic process (GO:0046950) | 2.53623759 |
| 105 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.52705123 |
| 106 | focal adhesion assembly (GO:0048041) | 2.52029100 |
| 107 | cell-substrate adherens junction assembly (GO:0007045) | 2.52029100 |
| 108 | proline transport (GO:0015824) | 2.51445879 |
| 109 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.50146762 |
| 110 | cellular modified amino acid catabolic process (GO:0042219) | 2.49993336 |
| 111 | DNA topological change (GO:0006265) | 2.49934684 |
| 112 | DNA duplex unwinding (GO:0032508) | 2.49285916 |
| 113 | metanephric nephron epithelium development (GO:0072243) | 2.49228903 |
| 114 | growth hormone receptor signaling pathway (GO:0060396) | 2.48993753 |
| 115 | valine metabolic process (GO:0006573) | 2.48717459 |
| 116 | embryonic process involved in female pregnancy (GO:0060136) | 2.48572000 |
| 117 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.48184797 |
| 118 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.47754206 |
| 119 | tryptophan catabolic process (GO:0006569) | 2.47730003 |
| 120 | indole-containing compound catabolic process (GO:0042436) | 2.47730003 |
| 121 | indolalkylamine catabolic process (GO:0046218) | 2.47730003 |
| 122 | cellular response to vitamin D (GO:0071305) | 2.47133439 |
| 123 | regulation of chromosome segregation (GO:0051983) | 2.45778635 |
| 124 | DNA strand elongation (GO:0022616) | 2.44756634 |
| 125 | adenine nucleotide transport (GO:0051503) | 2.44436131 |
| 126 | transcytosis (GO:0045056) | 2.43931526 |
| 127 | 4-hydroxyproline metabolic process (GO:0019471) | 2.43506194 |
| 128 | DNA-dependent DNA replication (GO:0006261) | 2.43413859 |
| 129 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.43085613 |
| 130 | L-phenylalanine metabolic process (GO:0006558) | 2.43085613 |
| 131 | nuclear export (GO:0051168) | 2.42956220 |
| 132 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.42360221 |
| 133 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.42360221 |
| 134 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.42360221 |
| 135 | metanephric nephron tubule development (GO:0072234) | 2.42126735 |
| 136 | metanephric tubule development (GO:0072170) | 2.42126735 |
| 137 | sodium ion export (GO:0071436) | 2.42016441 |
| 138 | peptidyl-threonine modification (GO:0018210) | 2.41972853 |
| 139 | modified amino acid transport (GO:0072337) | 2.41872432 |
| 140 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.41343595 |
| 141 | histone H2A monoubiquitination (GO:0035518) | 2.40743714 |
| 142 | cellular potassium ion homeostasis (GO:0030007) | 2.39963064 |
| 143 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.39506155 |
| 144 | regulation of DNA damage checkpoint (GO:2000001) | 2.38138776 |
| 145 | tryptophan metabolic process (GO:0006568) | 2.38109655 |
| 146 | pinocytosis (GO:0006907) | 2.38072889 |
| 147 | vitamin D metabolic process (GO:0042359) | 2.37787365 |
| 148 | purine ribonucleotide transport (GO:0015868) | 2.37640804 |
| 149 | L-phenylalanine catabolic process (GO:0006559) | 2.36747758 |
| 150 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.36747758 |
| 151 | layer formation in cerebral cortex (GO:0021819) | 2.36516481 |
| 152 | low-density lipoprotein particle clearance (GO:0034383) | 2.36042111 |
| 153 | regulation of early endosome to late endosome transport (GO:2000641) | 2.35507822 |
| 154 | kynurenine metabolic process (GO:0070189) | 2.33812956 |
| 155 | amino-acid betaine metabolic process (GO:0006577) | 2.33511372 |
| 156 | 2-oxoglutarate metabolic process (GO:0006103) | 2.31337120 |
| 157 | regulation of cholesterol homeostasis (GO:2000188) | 2.31310492 |
| 158 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.31217548 |
| 159 | cellular response to vitamin (GO:0071295) | 2.31109411 |
| 160 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.30987129 |
| 161 | clathrin coat assembly (GO:0048268) | 2.29549186 |
| 162 | hypotonic response (GO:0006971) | 2.27167498 |
| 163 | toxin transport (GO:1901998) | 2.26212466 |
| 164 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.25645004 |
| 165 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.22739709 |
| 166 | stress fiber assembly (GO:0043149) | 2.22598109 |
| 167 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.21577079 |
| 168 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.20953446 |
| 169 | serine family amino acid catabolic process (GO:0009071) | 2.20690145 |
| 170 | carnitine transport (GO:0015879) | 2.20330975 |
| 171 | amino-acid betaine transport (GO:0015838) | 2.20330975 |
| 172 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.18518254 |
| 173 | urea metabolic process (GO:0019627) | 2.17695906 |
| 174 | urea cycle (GO:0000050) | 2.17695906 |
| 175 | positive regulation of glycolytic process (GO:0045821) | 2.15761432 |
| 176 | vitamin transport (GO:0051180) | 2.15289648 |
| 177 | ketone body metabolic process (GO:1902224) | 2.15286300 |
| 178 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.14965549 |
| 179 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.14771678 |
| 180 | negative regulation of fatty acid transport (GO:2000192) | 2.14515461 |
| 181 | neurotransmitter biosynthetic process (GO:0042136) | 2.13614493 |
| 182 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.09997751 |
| 183 | response to magnesium ion (GO:0032026) | 2.09468038 |
| 184 | metanephric epithelium development (GO:0072207) | 2.09139299 |
| 185 | regulation of hippo signaling (GO:0035330) | 2.07976266 |
| 186 | alanine transport (GO:0032328) | 2.07958680 |
| 187 | peptide catabolic process (GO:0043171) | 2.07914191 |
| 188 | regulation of cholesterol storage (GO:0010885) | 2.07029218 |
| 189 | response to phenylpropanoid (GO:0080184) | 2.06953032 |
| 190 | bone resorption (GO:0045453) | 2.06945338 |
| 191 | cellular response to growth hormone stimulus (GO:0071378) | 2.06846394 |
| 192 | negative regulation of lipid transport (GO:0032369) | 2.06366835 |
| 193 | surfactant homeostasis (GO:0043129) | 2.05605630 |
| 194 | endocytic recycling (GO:0032456) | 2.04931932 |
| 195 | wound healing, spreading of epidermal cells (GO:0035313) | 2.04574910 |
| 196 | hippo signaling (GO:0035329) | 2.04173580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 8.76399585 |
| 2 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 4.86018634 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.87317598 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.23133880 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.02674655 |
| 6 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.94415352 |
| 7 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.90305917 |
| 8 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.89410908 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.64137460 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.61830113 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.52021713 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.48795578 |
| 13 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.45403958 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.45197291 |
| 15 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.43914434 |
| 16 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.29599642 |
| 17 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.28063978 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.27538861 |
| 19 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.27345263 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.25975244 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.25354831 |
| 22 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.12395755 |
| 23 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 2.06692485 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.03093864 |
| 25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.99926996 |
| 26 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.98421834 |
| 27 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.97473409 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.95013358 |
| 29 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.93305322 |
| 30 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.93305322 |
| 31 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.93305322 |
| 32 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.92678463 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.91971221 |
| 34 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.90396425 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.88706010 |
| 36 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.86830830 |
| 37 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81700232 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.76707375 |
| 39 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.71977082 |
| 40 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.70530302 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.70174302 |
| 42 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.70067878 |
| 43 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.69655869 |
| 44 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.69040383 |
| 45 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.69040383 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.66295217 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64551686 |
| 48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.64478213 |
| 49 | RXR_22108803_ChIP-Seq_LS180_Human | 1.63359536 |
| 50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63057363 |
| 51 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.59547915 |
| 52 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.56912824 |
| 53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.56396532 |
| 54 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.55588857 |
| 55 | CJUN_26792858_Chip-Seq_BT549_Human | 1.53303262 |
| 56 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.51578780 |
| 57 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.49526384 |
| 58 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.45589334 |
| 59 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44152212 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.42465462 |
| 61 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.40841045 |
| 62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.40603378 |
| 63 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.40585363 |
| 64 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.40331560 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39637009 |
| 66 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.39278558 |
| 67 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.38307867 |
| 68 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.38025230 |
| 69 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36729056 |
| 70 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.34648169 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.33885069 |
| 72 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.32995558 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.32755716 |
| 74 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.32715753 |
| 75 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.32378434 |
| 76 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.31082254 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.28365728 |
| 78 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.26621748 |
| 79 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.26439854 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26059410 |
| 81 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.25894282 |
| 82 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25626542 |
| 83 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.25111501 |
| 84 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.23828971 |
| 85 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23611254 |
| 86 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.23518060 |
| 87 | TP53_16413492_ChIP-PET_HCT116_Human | 1.23132314 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22995461 |
| 89 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22258281 |
| 90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21174081 |
| 91 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.19825621 |
| 92 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.19506272 |
| 93 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.19334168 |
| 94 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.18861008 |
| 95 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18788376 |
| 96 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17498793 |
| 97 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16956609 |
| 98 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.15429571 |
| 99 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.11389750 |
| 100 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10525077 |
| 101 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09998718 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09903548 |
| 103 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.09763953 |
| 104 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.09739279 |
| 105 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.08648430 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08281761 |
| 107 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07205880 |
| 108 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06908516 |
| 109 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.05965829 |
| 110 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.05942095 |
| 111 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.05337045 |
| 112 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03554101 |
| 113 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03094140 |
| 114 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03065604 |
| 115 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.02945535 |
| 116 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.02869941 |
| 117 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.02853675 |
| 118 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.02524269 |
| 119 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02281298 |
| 120 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02272528 |
| 121 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.02114967 |
| 122 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01529510 |
| 123 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01529510 |
| 124 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00961357 |
| 125 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00411455 |
| 126 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.00181524 |
| 127 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.00141114 |
| 128 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00128296 |
| 129 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00037879 |
| 130 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99800423 |
| 131 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99683644 |
| 132 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99529354 |
| 133 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99389665 |
| 134 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.99184450 |
| 135 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.99181571 |
| 136 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.98753761 |
| 137 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98237939 |
| 138 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97692510 |
| 139 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97650075 |
| 140 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.97426322 |
| 141 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97336707 |
| 142 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97152530 |
| 143 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.96779119 |
| 144 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.96581196 |
| 145 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95809202 |
| 146 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94986019 |
| 147 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94038416 |
| 148 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.93963530 |
| 149 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.93641002 |
| 150 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.93524323 |
| 151 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.93523669 |
| 152 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.93073960 |
| 153 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92931052 |
| 154 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92123548 |
| 155 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92058973 |
| 156 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.91572293 |
| 157 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90931835 |
| 158 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.90793576 |
| 159 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90758640 |
| 160 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90384030 |
| 161 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.89991959 |
| 162 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.89984939 |
| 163 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.89913436 |
| 164 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.89387390 |
| 165 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.88452920 |
| 166 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.88296299 |
| 167 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.87578973 |
| 168 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.86957705 |
| 169 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84787650 |
| 170 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.83635273 |
| 171 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83055301 |
| 172 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.80531791 |
| 173 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.80356880 |
| 174 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.79531698 |
| 175 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.79025644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.34289705 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.75655620 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.65892584 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 3.58386940 |
| 5 | MP0004043_abnormal_pH_regulation | 3.40548314 |
| 6 | MP0003693_abnormal_embryo_hatching | 3.05735256 |
| 7 | MP0003300_gastrointestinal_ulcer | 3.02549369 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 2.98513373 |
| 9 | MP0008057_abnormal_DNA_replication | 2.92166152 |
| 10 | MP0003195_calcinosis | 2.83266661 |
| 11 | MP0003252_abnormal_bile_duct | 2.67581324 |
| 12 | MP0005332_abnormal_amino_acid | 2.64605777 |
| 13 | MP0002138_abnormal_hepatobiliary_system | 2.64577423 |
| 14 | MP0003941_abnormal_skin_development | 2.64329769 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.62557989 |
| 16 | MP0003111_abnormal_nucleus_morphology | 2.61224304 |
| 17 | MP0001730_embryonic_growth_arrest | 2.46109936 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 2.38167668 |
| 19 | MP0005451_abnormal_body_composition | 2.29436735 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.11761419 |
| 21 | MP0001765_abnormal_ion_homeostasis | 2.11557954 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 2.11399911 |
| 23 | MP0008260_abnormal_autophagy | 2.10790604 |
| 24 | MP0009643_abnormal_urine_homeostasis | 2.10117223 |
| 25 | MP0010094_abnormal_chromosome_stability | 2.08730104 |
| 26 | MP0003077_abnormal_cell_cycle | 2.00677256 |
| 27 | MP0001756_abnormal_urination | 2.00034891 |
| 28 | MP0002796_impaired_skin_barrier | 1.96719292 |
| 29 | MP0008932_abnormal_embryonic_tissue | 1.95733347 |
| 30 | MP0005058_abnormal_lysosome_morphology | 1.91471155 |
| 31 | MP0005167_abnormal_blood-brain_barrier | 1.90916964 |
| 32 | MP0003303_peritoneal_inflammation | 1.88709996 |
| 33 | MP0010307_abnormal_tumor_latency | 1.81117828 |
| 34 | MP0001958_emphysema | 1.75530721 |
| 35 | MP0000350_abnormal_cell_proliferation | 1.74626754 |
| 36 | MP0003890_abnormal_embryonic-extraembry | 1.68739738 |
| 37 | MP0003283_abnormal_digestive_organ | 1.68146110 |
| 38 | MP0001672_abnormal_embryogenesis/_devel | 1.67242372 |
| 39 | MP0005380_embryogenesis_phenotype | 1.67242372 |
| 40 | MP0002136_abnormal_kidney_physiology | 1.67229462 |
| 41 | MP0002896_abnormal_bone_mineralization | 1.65703169 |
| 42 | MP0002086_abnormal_extraembryonic_tissu | 1.64958991 |
| 43 | MP0005365_abnormal_bile_salt | 1.63746663 |
| 44 | MP0008438_abnormal_cutaneous_collagen | 1.63162184 |
| 45 | MP0008961_abnormal_basal_metabolism | 1.63023014 |
| 46 | MP0001697_abnormal_embryo_size | 1.62021307 |
| 47 | MP0008875_abnormal_xenobiotic_pharmacok | 1.61871621 |
| 48 | MP0004272_abnormal_basement_membrane | 1.58398866 |
| 49 | MP0002088_abnormal_embryonic_growth/wei | 1.55390639 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.54544937 |
| 51 | MP0003984_embryonic_growth_retardation | 1.53804130 |
| 52 | MP0004782_abnormal_surfactant_physiolog | 1.53742247 |
| 53 | MP0000762_abnormal_tongue_morphology | 1.52357404 |
| 54 | MP0002080_prenatal_lethality | 1.51506931 |
| 55 | MP0009672_abnormal_birth_weight | 1.51463223 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.51327258 |
| 57 | MP0002697_abnormal_eye_size | 1.50526986 |
| 58 | MP0002085_abnormal_embryonic_tissue | 1.45896999 |
| 59 | MP0005076_abnormal_cell_differentiation | 1.45606846 |
| 60 | MP0008007_abnormal_cellular_replicative | 1.42892740 |
| 61 | MP0002084_abnormal_developmental_patter | 1.42761816 |
| 62 | MP0004859_abnormal_synaptic_plasticity | 1.42086024 |
| 63 | MP0002249_abnormal_larynx_morphology | 1.40007179 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.39419239 |
| 65 | MP0002009_preneoplasia | 1.37298366 |
| 66 | MP0002168_other_aberrant_phenotype | 1.37287425 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.35755796 |
| 68 | MP0003566_abnormal_cell_adhesion | 1.34672254 |
| 69 | MP0003075_altered_response_to | 1.33787750 |
| 70 | MP0005501_abnormal_skin_physiology | 1.30673515 |
| 71 | MP0000604_amyloidosis | 1.30022284 |
| 72 | MP0001216_abnormal_epidermal_layer | 1.28733353 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 1.28244233 |
| 74 | MP0001849_ear_inflammation | 1.28087606 |
| 75 | MP0002396_abnormal_hematopoietic_system | 1.27355189 |
| 76 | MP0005248_abnormal_Harderian_gland | 1.25990280 |
| 77 | MP0001881_abnormal_mammary_gland | 1.25813997 |
| 78 | MP0004264_abnormal_extraembryonic_tissu | 1.25228186 |
| 79 | MP0004858_abnormal_nervous_system | 1.24168354 |
| 80 | MP0005166_decreased_susceptibility_to | 1.21666088 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.21334113 |
| 82 | MP0003091_abnormal_cell_migration | 1.19494196 |
| 83 | MP0002233_abnormal_nose_morphology | 1.18761560 |
| 84 | MP0000428_abnormal_craniofacial_morphol | 1.18578756 |
| 85 | MP0000432_abnormal_head_morphology | 1.17873842 |
| 86 | MP0003935_abnormal_craniofacial_develop | 1.17498033 |
| 87 | MP0004233_abnormal_muscle_weight | 1.16759415 |
| 88 | MP0003567_abnormal_fetal_cardiomyocyte | 1.16028259 |
| 89 | MP0003045_fibrosis | 1.15711441 |
| 90 | MP0009697_abnormal_copulation | 1.13912485 |
| 91 | MP0003172_abnormal_lysosome_physiology | 1.12733130 |
| 92 | MP0005084_abnormal_gallbladder_morpholo | 1.12313830 |
| 93 | MP0001666_abnormal_nutrient_absorption | 1.11887912 |
| 94 | MP0006054_spinal_hemorrhage | 1.11762463 |
| 95 | MP0002928_abnormal_bile_duct | 1.11171094 |
| 96 | MP0005621_abnormal_cell_physiology | 1.10876571 |
| 97 | MP0003950_abnormal_plasma_membrane | 1.09084429 |
| 98 | MP0010329_abnormal_lipoprotein_level | 1.08545496 |
| 99 | MP0009053_abnormal_anal_canal | 1.08380413 |
| 100 | MP0003329_amyloid_beta_deposits | 1.07887387 |
| 101 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.06375184 |
| 102 | MP0004197_abnormal_fetal_growth/weight/ | 1.06168909 |
| 103 | MP0002060_abnormal_skin_morphology | 1.05147829 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 1.04680560 |
| 105 | MP0005535_abnormal_body_temperature | 1.02139900 |
| 106 | MP0000313_abnormal_cell_death | 1.02076315 |
| 107 | MP0010368_abnormal_lymphatic_system | 1.01175008 |
| 108 | MP0000490_abnormal_crypts_of | 0.97903063 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.97118035 |
| 110 | MP0000678_abnormal_parathyroid_gland | 0.96123983 |
| 111 | MP0005666_abnormal_adipose_tissue | 0.95298844 |
| 112 | MP0002295_abnormal_pulmonary_circulatio | 0.95169420 |
| 113 | MP0000537_abnormal_urethra_morphology | 0.93901040 |
| 114 | MP0000538_abnormal_urinary_bladder | 0.93798652 |
| 115 | MP0002118_abnormal_lipid_homeostasis | 0.92659693 |
| 116 | MP0000609_abnormal_liver_physiology | 0.91396200 |
| 117 | MP0004130_abnormal_muscle_cell | 0.90722865 |
| 118 | MP0001177_atelectasis | 0.89953986 |
| 119 | MP0009250_abnormal_appendicular_skeleto | 0.89255958 |
| 120 | MP0000627_abnormal_mammary_gland | 0.88660648 |
| 121 | MP0008004_abnormal_stomach_pH | 0.87390165 |
| 122 | MP0005384_cellular_phenotype | 0.87016253 |
| 123 | MP0002254_reproductive_system_inflammat | 0.86858568 |
| 124 | MP0009764_decreased_sensitivity_to | 0.86719643 |
| 125 | MP0000613_abnormal_salivary_gland | 0.86439405 |
| 126 | MP0005023_abnormal_wound_healing | 0.84546846 |
| 127 | MP0010630_abnormal_cardiac_muscle | 0.84542541 |
| 128 | MP0003942_abnormal_urinary_system | 0.84367702 |
| 129 | MP0003755_abnormal_palate_morphology | 0.83922414 |
| 130 | MP0002909_abnormal_adrenal_gland | 0.83168784 |
| 131 | MP0003943_abnormal_hepatobiliary_system | 0.82456031 |
| 132 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82103764 |
| 133 | MP0001286_abnormal_eye_development | 0.81671494 |
| 134 | MP0009703_decreased_birth_body | 0.81024891 |
| 135 | MP0003937_abnormal_limbs/digits/tail_de | 0.79819899 |
| 136 | MP0005375_adipose_tissue_phenotype | 0.79546715 |
| 137 | MP0002925_abnormal_cardiovascular_devel | 0.79319640 |
| 138 | MP0004270_analgesia | 0.79078315 |
| 139 | MP0005377_hearing/vestibular/ear_phenot | 0.78648790 |
| 140 | MP0003878_abnormal_ear_physiology | 0.78648790 |
| 141 | MP0000049_abnormal_middle_ear | 0.78476974 |
| 142 | MP0000003_abnormal_adipose_tissue | 0.78312499 |
| 143 | MP0003385_abnormal_body_wall | 0.77992062 |
| 144 | MP0005164_abnormal_response_to | 0.77959510 |
| 145 | MP0009931_abnormal_skin_appearance | 0.77504580 |
| 146 | MP0002092_abnormal_eye_morphology | 0.76921975 |
| 147 | MP0004484_altered_response_of | 0.76409402 |
| 148 | MP0000013_abnormal_adipose_tissue | 0.75393456 |
| 149 | MP0005257_abnormal_intraocular_pressure | 0.75346484 |
| 150 | MP0001293_anophthalmia | 0.73265543 |
| 151 | MP0005083_abnormal_biliary_tract | 0.72886309 |
| 152 | MP0001533_abnormal_skeleton_physiology | 0.72553895 |
| 153 | MP0000579_abnormal_nail_morphology | 0.72189942 |
| 154 | MP0003115_abnormal_respiratory_system | 0.72051120 |
| 155 | MP0008058_abnormal_DNA_repair | 0.71657358 |
| 156 | MP0004885_abnormal_endolymph | 0.70921718 |
| 157 | MP0000230_abnormal_systemic_arterial | 0.70878083 |
| 158 | MP0002135_abnormal_kidney_morphology | 0.69702121 |
| 159 | MP0001879_abnormal_lymphatic_vessel | 0.69360634 |
| 160 | MP0001299_abnormal_eye_distance/ | 0.68941608 |
| 161 | MP0003448_altered_tumor_morphology | 0.68745130 |
| 162 | MP0000858_altered_metastatic_potential | 0.68679890 |
| 163 | MP0002115_abnormal_skeleton_extremities | 0.67878938 |
| 164 | MP0003795_abnormal_bone_structure | 0.67450443 |
| 165 | MP0005275_abnormal_skin_tensile | 0.67325740 |
| 166 | MP0005395_other_phenotype | 0.66876442 |
| 167 | MP0000377_abnormal_hair_follicle | 0.65909947 |
| 168 | MP0002089_abnormal_postnatal_growth/wei | 0.65068669 |
| 169 | MP0002822_catalepsy | 0.64672946 |
| 170 | MP0003690_abnormal_glial_cell | 0.62486163 |
| 171 | MP0001915_intracranial_hemorrhage | 0.62003010 |
| 172 | MP0003868_abnormal_feces_composition | 0.61797881 |
| 173 | MP0000598_abnormal_liver_morphology | 0.60756728 |
| 174 | MP0009384_cardiac_valve_regurgitation | 0.60196371 |
| 175 | MP0002078_abnormal_glucose_homeostasis | 0.58790569 |
| 176 | MP0003453_abnormal_keratinocyte_physiol | 0.58364775 |
| 177 | MP0010386_abnormal_urinary_bladder | 0.56937694 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Reduced antithrombin III activity (HP:0001976) | 4.74697080 |
| 2 | Metabolic alkalosis (HP:0200114) | 4.59364960 |
| 3 | Abnormality of chloride homeostasis (HP:0011422) | 4.54957913 |
| 4 | Gout (HP:0001997) | 4.51115394 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 4.50433786 |
| 6 | Increased circulating renin level (HP:0000848) | 4.49962991 |
| 7 | Hypokalemic alkalosis (HP:0001949) | 4.38082805 |
| 8 | Abnormality of the intrinsic pathway (HP:0010989) | 4.23555689 |
| 9 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.02501468 |
| 10 | Long nose (HP:0003189) | 3.49333988 |
| 11 | Polyuria (HP:0000103) | 3.35530951 |
| 12 | Abnormal urine output (HP:0012590) | 3.31610011 |
| 13 | Abnormality of renal excretion (HP:0011036) | 3.30758402 |
| 14 | Hypomagnesemia (HP:0002917) | 3.29502206 |
| 15 | Increased purine levels (HP:0004368) | 3.29102251 |
| 16 | Hyperuricemia (HP:0002149) | 3.29102251 |
| 17 | Abnormality of purine metabolism (HP:0004352) | 3.27922893 |
| 18 | Hydroxyprolinuria (HP:0003080) | 3.24331661 |
| 19 | Abnormality of proline metabolism (HP:0010907) | 3.24331661 |
| 20 | Overlapping toe (HP:0001845) | 3.22478408 |
| 21 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.08769333 |
| 22 | Proximal tubulopathy (HP:0000114) | 3.08298803 |
| 23 | Chromsome breakage (HP:0040012) | 2.98980276 |
| 24 | Ankyloglossia (HP:0010296) | 2.91002863 |
| 25 | Tetany (HP:0001281) | 2.89782852 |
| 26 | Oligodontia (HP:0000677) | 2.86165974 |
| 27 | Abnormality of renin-angiotensin system (HP:0000847) | 2.85479324 |
| 28 | Conical tooth (HP:0000698) | 2.85403750 |
| 29 | Alkalosis (HP:0001948) | 2.82658359 |
| 30 | Abnormality of magnesium homeostasis (HP:0004921) | 2.75706275 |
| 31 | Achilles tendon contracture (HP:0001771) | 2.70797710 |
| 32 | Capillary hemangiomas (HP:0005306) | 2.67737552 |
| 33 | Hyperaldosteronism (HP:0000859) | 2.66863327 |
| 34 | Abnormal drinking behavior (HP:0030082) | 2.65196767 |
| 35 | Polydipsia (HP:0001959) | 2.65196767 |
| 36 | Hyperglycinuria (HP:0003108) | 2.60125564 |
| 37 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.59176063 |
| 38 | Acute lymphatic leukemia (HP:0006721) | 2.57686275 |
| 39 | Spinal cord lesions (HP:0100561) | 2.53479223 |
| 40 | Syringomyelia (HP:0003396) | 2.53479223 |
| 41 | Deep philtrum (HP:0002002) | 2.53096659 |
| 42 | Thin bony cortex (HP:0002753) | 2.52623421 |
| 43 | Abnormality of the Achilles tendon (HP:0005109) | 2.51695973 |
| 44 | Ketoacidosis (HP:0001993) | 2.49647619 |
| 45 | Renal salt wasting (HP:0000127) | 2.47448750 |
| 46 | Pseudobulbar signs (HP:0002200) | 2.46967562 |
| 47 | Diastasis recti (HP:0001540) | 2.45538987 |
| 48 | Lymphangioma (HP:0100764) | 2.44569954 |
| 49 | Heterotopia (HP:0002282) | 2.43764098 |
| 50 | Neoplasm of the oral cavity (HP:0100649) | 2.43565675 |
| 51 | Hypercalciuria (HP:0002150) | 2.35586490 |
| 52 | Hypokalemia (HP:0002900) | 2.34484625 |
| 53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.31777227 |
| 54 | Cardiovascular calcification (HP:0011915) | 2.30907103 |
| 55 | Abnormality of the salivary glands (HP:0010286) | 2.30682505 |
| 56 | Acute myeloid leukemia (HP:0004808) | 2.30613856 |
| 57 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.29705727 |
| 58 | Mucopolysacchariduria (HP:0008155) | 2.29705727 |
| 59 | Absent eyebrow (HP:0002223) | 2.29438470 |
| 60 | Vascular calcification (HP:0004934) | 2.26060105 |
| 61 | Leiomyosarcoma (HP:0100243) | 2.25710852 |
| 62 | Uterine leiomyosarcoma (HP:0002891) | 2.25710852 |
| 63 | Sensorimotor neuropathy (HP:0007141) | 2.23339442 |
| 64 | Asymmetry of the thorax (HP:0001555) | 2.22725551 |
| 65 | Protrusio acetabuli (HP:0003179) | 2.21794217 |
| 66 | Axonal loss (HP:0003447) | 2.20373696 |
| 67 | Upper motor neuron abnormality (HP:0002127) | 2.19351691 |
| 68 | Myocardial infarction (HP:0001658) | 2.19144246 |
| 69 | Abnormality of potassium homeostasis (HP:0011042) | 2.19104135 |
| 70 | Subacute progressive viral hepatitis (HP:0006572) | 2.19014159 |
| 71 | Cervical subluxation (HP:0003308) | 2.18494092 |
| 72 | Type I transferrin isoform profile (HP:0003642) | 2.17442302 |
| 73 | Premature rupture of membranes (HP:0001788) | 2.17316099 |
| 74 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.16713185 |
| 75 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.14943442 |
| 76 | Abnormality of glycine metabolism (HP:0010895) | 2.14943442 |
| 77 | Gastrointestinal carcinoma (HP:0002672) | 2.14208950 |
| 78 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.14208950 |
| 79 | Abnormality of oral frenula (HP:0000190) | 2.10993355 |
| 80 | Nephrolithiasis (HP:0000787) | 2.07915566 |
| 81 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07218566 |
| 82 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07218566 |
| 83 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07218566 |
| 84 | Dysostosis multiplex (HP:0000943) | 2.07131676 |
| 85 | Hypophosphatemia (HP:0002148) | 2.06830345 |
| 86 | Deep venous thrombosis (HP:0002625) | 2.04224462 |
| 87 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.03782983 |
| 88 | Metaphyseal cupping (HP:0003021) | 2.03661631 |
| 89 | Renal tubular acidosis (HP:0001947) | 2.01774407 |
| 90 | Xanthomatosis (HP:0000991) | 2.01636817 |
| 91 | Anal stenosis (HP:0002025) | 2.00407168 |
| 92 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.00099976 |
| 93 | Cerebral aneurysm (HP:0004944) | 1.99990931 |
| 94 | Papilledema (HP:0001085) | 1.99855331 |
| 95 | Unilateral renal agenesis (HP:0000122) | 1.99321345 |
| 96 | Ketosis (HP:0001946) | 1.98775051 |
| 97 | Chondrocalcinosis (HP:0000934) | 1.98473441 |
| 98 | Arnold-Chiari malformation (HP:0002308) | 1.98224329 |
| 99 | Embryonal renal neoplasm (HP:0011794) | 1.97048773 |
| 100 | Esophageal varix (HP:0002040) | 1.96752090 |
| 101 | Wide nose (HP:0000445) | 1.96657736 |
| 102 | Focal segmental glomerulosclerosis (HP:0000097) | 1.96164707 |
| 103 | Increased nuchal translucency (HP:0010880) | 1.95681310 |
| 104 | Glomerulosclerosis (HP:0000096) | 1.93680341 |
| 105 | Rickets (HP:0002748) | 1.90316641 |
| 106 | Protuberant abdomen (HP:0001538) | 1.89512232 |
| 107 | Selective tooth agenesis (HP:0001592) | 1.88069107 |
| 108 | Abnormality of the lumbar spine (HP:0100712) | 1.86766799 |
| 109 | Mitral valve prolapse (HP:0001634) | 1.86482778 |
| 110 | Hand muscle atrophy (HP:0009130) | 1.86345487 |
| 111 | Hyperacusis (HP:0010780) | 1.86078946 |
| 112 | Deviation of the thumb (HP:0009603) | 1.86075641 |
| 113 | Disproportionate tall stature (HP:0001519) | 1.84420401 |
| 114 | Hematochezia (HP:0002573) | 1.83744164 |
| 115 | Upper limb amyotrophy (HP:0009129) | 1.83649763 |
| 116 | Distal upper limb amyotrophy (HP:0007149) | 1.83649763 |
| 117 | Insomnia (HP:0100785) | 1.83480429 |
| 118 | Skull defect (HP:0001362) | 1.83429152 |
| 119 | Abnormal foot bone ossification (HP:0010675) | 1.80132582 |
| 120 | Thin skin (HP:0000963) | 1.79692259 |
| 121 | Spastic diplegia (HP:0001264) | 1.79680267 |
| 122 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.79620846 |
| 123 | Tubulointerstitial fibrosis (HP:0005576) | 1.79613129 |
| 124 | Potter facies (HP:0002009) | 1.79124538 |
| 125 | Facial shape deformation (HP:0011334) | 1.79124538 |
| 126 | Lower limb amyotrophy (HP:0007210) | 1.78902114 |
| 127 | Hepatocellular carcinoma (HP:0001402) | 1.78760403 |
| 128 | Abnormality of Sharpey fibers (HP:0100685) | 1.77805627 |
| 129 | Bladder neoplasm (HP:0009725) | 1.76080023 |
| 130 | Bladder carcinoma (HP:0002862) | 1.76080023 |
| 131 | Arterial tortuosity (HP:0005116) | 1.75406430 |
| 132 | Global brain atrophy (HP:0002283) | 1.74947963 |
| 133 | Vascular tortuosity (HP:0004948) | 1.73775520 |
| 134 | Broad palm (HP:0001169) | 1.73752274 |
| 135 | Progressive muscle weakness (HP:0003323) | 1.73312529 |
| 136 | Smooth philtrum (HP:0000319) | 1.72254687 |
| 137 | Vacuolated lymphocytes (HP:0001922) | 1.70753171 |
| 138 | Flat acetabular roof (HP:0003180) | 1.70506967 |
| 139 | Hyperphosphaturia (HP:0003109) | 1.70301341 |
| 140 | Preaxial foot polydactyly (HP:0001841) | 1.69936850 |
| 141 | Delayed epiphyseal ossification (HP:0002663) | 1.69689684 |
| 142 | Relative macrocephaly (HP:0004482) | 1.69421502 |
| 143 | Adrenal overactivity (HP:0002717) | 1.69418733 |
| 144 | Abnormal lung lobation (HP:0002101) | 1.69389577 |
| 145 | Glycosuria (HP:0003076) | 1.68200476 |
| 146 | Abnormality of urine glucose concentration (HP:0011016) | 1.68200476 |
| 147 | Aortic aneurysm (HP:0004942) | 1.68152559 |
| 148 | Macroorchidism (HP:0000053) | 1.67385532 |
| 149 | Disinhibition (HP:0000734) | 1.67354513 |
| 150 | Nonimmune hydrops fetalis (HP:0001790) | 1.66734983 |
| 151 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.66626523 |
| 152 | Back pain (HP:0003418) | 1.66379220 |
| 153 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.66042575 |
| 154 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.66042575 |
| 155 | Abnormality of glycolipid metabolism (HP:0010969) | 1.66042575 |
| 156 | Abnormality of the common coagulation pathway (HP:0010990) | 1.65842678 |
| 157 | Hyperammonemia (HP:0001987) | 1.65698218 |
| 158 | Genu recurvatum (HP:0002816) | 1.65353502 |
| 159 | Lower limb asymmetry (HP:0100559) | 1.65215239 |
| 160 | Hypoglycemic coma (HP:0001325) | 1.65190413 |
| 161 | Mitral stenosis (HP:0001718) | 1.64791872 |
| 162 | Rectal prolapse (HP:0002035) | 1.64787773 |
| 163 | Peritonitis (HP:0002586) | 1.64421577 |
| 164 | Proximal placement of thumb (HP:0009623) | 1.61403281 |
| 165 | Hepatoblastoma (HP:0002884) | 1.60659429 |
| 166 | Midface retrusion (HP:0011800) | 1.59759146 |
| 167 | Multiple enchondromatosis (HP:0005701) | 1.59469046 |
| 168 | Renal cell carcinoma (HP:0005584) | 1.58829890 |
| 169 | Multiple lipomas (HP:0001012) | 1.57990608 |
| 170 | Sandal gap (HP:0001852) | 1.57379592 |
| 171 | Breech presentation (HP:0001623) | 1.56546086 |
| 172 | Cubitus valgus (HP:0002967) | 1.55687805 |
| 173 | Uterine neoplasm (HP:0010784) | 1.54159458 |
| 174 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.53733362 |
| 175 | Transposition of the great arteries (HP:0001669) | 1.53733362 |
| 176 | Abnormal connection of the cardiac segments (HP:0011545) | 1.53733362 |
| 177 | Short middle phalanx of the 5th finger (HP:0004220) | 1.51628395 |
| 178 | Advanced eruption of teeth (HP:0006288) | 1.51489411 |
| 179 | Abnormal protein glycosylation (HP:0012346) | 1.50085207 |
| 180 | Abnormal glycosylation (HP:0012345) | 1.50085207 |
| 181 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.50085207 |
| 182 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.50085207 |
| 183 | Facial cleft (HP:0002006) | 1.49361990 |
| 184 | Insidious onset (HP:0003587) | 1.49139798 |
| 185 | Termporal pattern (HP:0011008) | 1.49139798 |
| 186 | Cortical dysplasia (HP:0002539) | 1.48518609 |
| 187 | Thoracic kyphosis (HP:0002942) | 1.48157737 |
| 188 | Abnormality of chromosome stability (HP:0003220) | 1.47858556 |
| 189 | Missing ribs (HP:0000921) | 1.47450570 |
| 190 | Abnormality of the thoracic spine (HP:0100711) | 1.46465217 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 3.95716249 |
| 2 | CDK12 | 3.41716005 |
| 3 | WNK3 | 3.19712885 |
| 4 | FRK | 2.94120863 |
| 5 | LATS1 | 2.87046881 |
| 6 | CDC42BPA | 2.83203591 |
| 7 | TRIB3 | 2.44624513 |
| 8 | OXSR1 | 2.39841887 |
| 9 | PKN2 | 2.34416345 |
| 10 | LATS2 | 2.29409341 |
| 11 | TTK | 2.23489819 |
| 12 | BCR | 2.21102565 |
| 13 | PRPF4B | 2.09389537 |
| 14 | EIF2AK3 | 2.05972857 |
| 15 | EEF2K | 2.05537327 |
| 16 | SMG1 | 2.03585890 |
| 17 | MAP3K9 | 1.98789867 |
| 18 | MAP3K2 | 1.98264548 |
| 19 | IRAK3 | 1.97132460 |
| 20 | EIF2AK1 | 1.88269931 |
| 21 | KSR2 | 1.80733758 |
| 22 | RIPK1 | 1.79331040 |
| 23 | ICK | 1.78488793 |
| 24 | CDC7 | 1.77086801 |
| 25 | MAP3K10 | 1.73877525 |
| 26 | BRD4 | 1.70861898 |
| 27 | ERN1 | 1.67055717 |
| 28 | PDGFRA | 1.65496472 |
| 29 | CDK3 | 1.63794087 |
| 30 | STK38 | 1.56875528 |
| 31 | STK38L | 1.52005955 |
| 32 | SCYL2 | 1.50987047 |
| 33 | MST1R | 1.46919814 |
| 34 | DDR2 | 1.46322888 |
| 35 | TAOK1 | 1.44709010 |
| 36 | STK24 | 1.40923905 |
| 37 | PBK | 1.40476254 |
| 38 | NME2 | 1.40171294 |
| 39 | STK3 | 1.34097133 |
| 40 | RIPK4 | 1.33349675 |
| 41 | FGFR4 | 1.33012503 |
| 42 | TSSK6 | 1.31756880 |
| 43 | NTRK3 | 1.31131249 |
| 44 | TNIK | 1.30975203 |
| 45 | PTK6 | 1.30627451 |
| 46 | TAF1 | 1.26280353 |
| 47 | WNK1 | 1.24823186 |
| 48 | NEK1 | 1.23938986 |
| 49 | NEK9 | 1.23568378 |
| 50 | MAP3K13 | 1.23232252 |
| 51 | BUB1 | 1.23036692 |
| 52 | MKNK1 | 1.22343694 |
| 53 | SIK1 | 1.21263323 |
| 54 | PRKD3 | 1.16498010 |
| 55 | MAP3K8 | 1.16232355 |
| 56 | NTRK1 | 1.15824044 |
| 57 | SIK2 | 1.15490606 |
| 58 | STK39 | 1.15086466 |
| 59 | RPS6KB2 | 1.14943932 |
| 60 | RPS6KA4 | 1.13160577 |
| 61 | ALK | 1.12935406 |
| 62 | SRPK1 | 1.12530392 |
| 63 | EPHA4 | 1.11016076 |
| 64 | SGK3 | 1.10727189 |
| 65 | RET | 1.10350585 |
| 66 | ERBB4 | 1.10089725 |
| 67 | EPHA2 | 1.08326954 |
| 68 | CAMKK1 | 1.07352480 |
| 69 | CLK1 | 1.06800514 |
| 70 | BMX | 1.06277833 |
| 71 | ABL2 | 1.06215002 |
| 72 | PTK2 | 1.06088422 |
| 73 | TAOK3 | 1.04358494 |
| 74 | FER | 1.02957843 |
| 75 | MINK1 | 0.99613284 |
| 76 | MOS | 0.97857597 |
| 77 | CDK7 | 0.96278726 |
| 78 | NEK2 | 0.95933596 |
| 79 | PAK3 | 0.95209429 |
| 80 | PRKCH | 0.93560852 |
| 81 | FGFR3 | 0.93347182 |
| 82 | MAP2K4 | 0.92918442 |
| 83 | EPHB2 | 0.91214716 |
| 84 | PASK | 0.88845632 |
| 85 | LRRK2 | 0.88200922 |
| 86 | MAP3K3 | 0.86313348 |
| 87 | MAP3K14 | 0.86073494 |
| 88 | MKNK2 | 0.86032300 |
| 89 | PDPK1 | 0.83304017 |
| 90 | CHEK1 | 0.82068893 |
| 91 | CDK6 | 0.81356452 |
| 92 | PLK4 | 0.81094435 |
| 93 | MELK | 0.79465679 |
| 94 | PDK2 | 0.79333015 |
| 95 | MTOR | 0.78631518 |
| 96 | PAK6 | 0.78308985 |
| 97 | PDGFRB | 0.76788283 |
| 98 | TGFBR2 | 0.76443398 |
| 99 | SGK223 | 0.75828328 |
| 100 | SGK494 | 0.75828328 |
| 101 | MAP3K1 | 0.75091715 |
| 102 | SIK3 | 0.74636803 |
| 103 | PDK1 | 0.74110759 |
| 104 | TAOK2 | 0.73361987 |
| 105 | BRSK2 | 0.72774998 |
| 106 | MAP3K4 | 0.71806585 |
| 107 | PLK2 | 0.71101212 |
| 108 | SGK2 | 0.70766690 |
| 109 | CSNK1G2 | 0.70187168 |
| 110 | CHEK2 | 0.70042008 |
| 111 | GSK3A | 0.69228154 |
| 112 | DMPK | 0.69103757 |
| 113 | PIK3CA | 0.68361570 |
| 114 | KSR1 | 0.67962729 |
| 115 | TYRO3 | 0.67646811 |
| 116 | WEE1 | 0.67141334 |
| 117 | MAP3K5 | 0.64725873 |
| 118 | ATM | 0.64692002 |
| 119 | JAK2 | 0.64419573 |
| 120 | MARK3 | 0.64367393 |
| 121 | SGK1 | 0.63761938 |
| 122 | BRAF | 0.63278617 |
| 123 | CDK4 | 0.63027483 |
| 124 | PTK2B | 0.62251456 |
| 125 | PLK3 | 0.61201489 |
| 126 | PLK1 | 0.60880985 |
| 127 | CAMK1G | 0.60577406 |
| 128 | MAP2K1 | 0.59983318 |
| 129 | STK10 | 0.58856115 |
| 130 | EPHB1 | 0.58629182 |
| 131 | TTN | 0.58518944 |
| 132 | PDK3 | 0.56693302 |
| 133 | PDK4 | 0.56693302 |
| 134 | YES1 | 0.56307998 |
| 135 | MARK1 | 0.54061626 |
| 136 | MET | 0.53308131 |
| 137 | CAMK1D | 0.52780182 |
| 138 | ARAF | 0.51986191 |
| 139 | FGFR1 | 0.51603307 |
| 140 | PNCK | 0.51047769 |
| 141 | MATK | 0.50590228 |
| 142 | FLT3 | 0.49489195 |
| 143 | PRKDC | 0.48766190 |
| 144 | PAK2 | 0.48059839 |
| 145 | EIF2AK2 | 0.46829517 |
| 146 | EGFR | 0.46615793 |
| 147 | PAK4 | 0.44511999 |
| 148 | JAK1 | 0.44118570 |
| 149 | STK11 | 0.43915994 |
| 150 | MAP3K6 | 0.41784924 |
| 151 | CDK2 | 0.41012288 |
| 152 | PRKAA1 | 0.41005420 |
| 153 | DAPK2 | 0.40060512 |
| 154 | INSR | 0.39793924 |
| 155 | CSNK1E | 0.39385097 |
| 156 | CDK1 | 0.37925139 |
| 157 | STK16 | 0.36466438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.98670654 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.84588064 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.51956607 |
| 4 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.42629250 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.17472295 |
| 6 | Thyroid cancer_Homo sapiens_hsa05216 | 2.15831542 |
| 7 | Cell cycle_Homo sapiens_hsa04110 | 2.12869177 |
| 8 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.09677996 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.08818741 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.06952763 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.04020859 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.04003819 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.03797074 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.98879471 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.98701217 |
| 16 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.89545266 |
| 17 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.89121143 |
| 18 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.78978891 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.75089502 |
| 20 | Spliceosome_Homo sapiens_hsa03040 | 1.61233282 |
| 21 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.59120761 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.59058973 |
| 23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.48402115 |
| 24 | Mismatch repair_Homo sapiens_hsa03430 | 1.44752336 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.44234550 |
| 26 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.42800019 |
| 27 | Other glycan degradation_Homo sapiens_hsa00511 | 1.41655256 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.40232268 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.38205106 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.37513331 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.29402170 |
| 32 | Colorectal cancer_Homo sapiens_hsa05210 | 1.29100068 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.28754394 |
| 34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.28680568 |
| 35 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.27007208 |
| 36 | Mineral absorption_Homo sapiens_hsa04978 | 1.25937161 |
| 37 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.19927073 |
| 38 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.17844968 |
| 39 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.15092620 |
| 40 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.14811071 |
| 41 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.10968645 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.10909489 |
| 43 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.08023306 |
| 44 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.08020238 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.07285522 |
| 46 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.07239767 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.07037000 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.06542871 |
| 49 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.05763800 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.01186978 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97953059 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.96546447 |
| 53 | Lysosome_Homo sapiens_hsa04142 | 0.95578184 |
| 54 | RNA degradation_Homo sapiens_hsa03018 | 0.94894977 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94278019 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.93494684 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93442633 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92572166 |
| 59 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.91147689 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.90754183 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.90690697 |
| 62 | Peroxisome_Homo sapiens_hsa04146 | 0.90104052 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 0.89998601 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.89707548 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87716848 |
| 66 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86608786 |
| 67 | Glioma_Homo sapiens_hsa05214 | 0.86467908 |
| 68 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86304341 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85597466 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.84478838 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.84193087 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.83698340 |
| 73 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82980428 |
| 74 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82145111 |
| 75 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82075455 |
| 76 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81178257 |
| 77 | Focal adhesion_Homo sapiens_hsa04510 | 0.80710569 |
| 78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.80210562 |
| 79 | Adherens junction_Homo sapiens_hsa04520 | 0.80095905 |
| 80 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.79710767 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77811721 |
| 82 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.77418056 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.76301335 |
| 84 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.76099644 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.75883358 |
| 86 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.74392906 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.73819786 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73214098 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.72828030 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72588693 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.71966218 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.71845971 |
| 93 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71805725 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71145947 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.70134659 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69639585 |
| 97 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.69368121 |
| 98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.69337216 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69306458 |
| 100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68952412 |
| 101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.68177430 |
| 102 | Measles_Homo sapiens_hsa05162 | 0.68048122 |
| 103 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67507798 |
| 104 | Cocaine addiction_Homo sapiens_hsa05030 | 0.67260281 |
| 105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66392465 |
| 106 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65036831 |
| 107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.64719399 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64528393 |
| 109 | Influenza A_Homo sapiens_hsa05164 | 0.64517205 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.63591856 |
| 111 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.60913990 |
| 112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60339996 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.60278649 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60235800 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60002838 |
| 116 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58908319 |
| 117 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58487423 |
| 118 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58271207 |
| 119 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58250594 |
| 120 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.57823912 |
| 121 | Base excision repair_Homo sapiens_hsa03410 | 0.57469424 |
| 122 | Renin secretion_Homo sapiens_hsa04924 | 0.57426999 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.56974196 |
| 124 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56542133 |
| 125 | Pathways in cancer_Homo sapiens_hsa05200 | 0.56405064 |
| 126 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55199144 |
| 127 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54613898 |
| 128 | Basal transcription factors_Homo sapiens_hsa03022 | 0.53652084 |
| 129 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52700031 |
| 130 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51966440 |
| 131 | Tight junction_Homo sapiens_hsa04530 | 0.51840080 |
| 132 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.51294414 |
| 133 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.51156607 |
| 134 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.50988483 |
| 135 | Endometrial cancer_Homo sapiens_hsa05213 | 0.49538634 |
| 136 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49488721 |
| 137 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47390039 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47104475 |
| 139 | Salivary secretion_Homo sapiens_hsa04970 | 0.47085020 |
| 140 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.46644510 |
| 141 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46522272 |
| 142 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45822497 |
| 143 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.45350196 |
| 144 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45218919 |
| 145 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44981656 |
| 146 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.44648632 |
| 147 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.44539264 |
| 148 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44312046 |
| 149 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.43929854 |
| 150 | Insulin secretion_Homo sapiens_hsa04911 | 0.43649805 |
| 151 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43642810 |
| 152 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.43602885 |
| 153 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.42899653 |
| 154 | Phagosome_Homo sapiens_hsa04145 | 0.42724721 |
| 155 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42328381 |
| 156 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42051190 |
| 157 | Melanoma_Homo sapiens_hsa05218 | 0.41920077 |
| 158 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.41751108 |
| 159 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.41185693 |
| 160 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.40988766 |
| 161 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.40839242 |
| 162 | Prostate cancer_Homo sapiens_hsa05215 | 0.40259228 |
| 163 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.40093102 |
| 164 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40021082 |
| 165 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39835731 |
| 166 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39416284 |
| 167 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.38954049 |

